Plenary session 1: Recent development of case-only studies in Asia-Pacific region
Saturday, October 12, 2024 |
18:15 - 19:15 |
Yasuda Auditorium |
Speaker
Dr. Kiyoshi Kubota
President
NPO Drug Safety Research Unit Japan
Keynote speaker: How to detect and remove biases specific to case-crossover studies
Abstract
In his talk, two biases are mentioned as biases specific to case-crossover studies which are particularly important when the exposure is chronic or successive. One of those biases is “bias due to within-subject exposure dependency” which is bias produced by the conditional logistic regression for matched case-control studies when the exposure status is NOT independent between periods. For binary exposure, this bias can be detected when the Mantel-Haenszel odds ratio (OR) is substantially different from the OR by the conditional logistic regression for matched case-control studies and can be removed by the Mantel-Haenszel method. The second type of bias is “bias due to lack of pairwise exchangeability” which is equivalent to “bias due to the exposure time trends” in many cases but can occur even without the exposure time trends on a population level. This bias can be detected when the OR of control subjects is substantially different from 1.0 and can be removed by the case-time-control approach. Those two biases can occur separately and simultaneously, and when they occur simultaneously, the simultaneous use of the remedies for these two biases (i.e., the Mantel-Haenszel method and case-time-control approach) is needed to remove them. Several relevant studies including those using real-world data and simulation studies are also explained.
Biography
Dr. Kiyoshi Kubota is a physician and a pharmacoepidemiologist. From 1991 to 1996 he worked at the Drug Safety Research Unit in England. He was Associate Professor (till 2008) and Professor (after 2008) of Department of Pharmacoepidemiology in Tokyo University from 1996 to 2014. He has been a member of the International Society for Pharmacoepidemiology (ISPE) since 1995. He worked as an Executive Committee Member of ISPE between 2015 August and 2018 August including 1 year between 2016 and 2017 when he was President of ISPE. He has been President of Japanese Society for Pharmacoepidemiology (JSPE) for 11 years from 2008 to 2019. He organized the ISPE’s 2nd Asian meeting in 2007 and the 5th Asian meeting in 2010 in Tokyo as the congress chair. He is currently President of NPO Drug Safety Research Unit Japan where he has been working since 2001.
Dr Angel Wong
Assistant Professor
angel.wong@lshtm.ac.uk
Co-presenter: Self-controlled case series: the best thing since sliced bread?
Abstract
Self-controlled case series (SCCS) has been used to investigate the association between drug or vaccine exposure and acute outcomes for post-market drug safety surveillance. As SCCS can eliminate time-invariant confounding by comparing risks of outcome within an individual, some studies used SCCS to complement cohort study design to obtain robust results.
In this plenary session, Angel will present her previous work on using active comparators in SCCS to reduce time-varying confounding and address protopathic bias using routine clinical data from Hong Kong. She will also discuss her recent work implementing SCCS in environmental pharmacoepidemiology using Japanese claims data linked to meteorological records. With these new applications of SCCS, is SCCS the best thing since sliced bread?
In this plenary session, Angel will present her previous work on using active comparators in SCCS to reduce time-varying confounding and address protopathic bias using routine clinical data from Hong Kong. She will also discuss her recent work implementing SCCS in environmental pharmacoepidemiology using Japanese claims data linked to meteorological records. With these new applications of SCCS, is SCCS the best thing since sliced bread?
Biography
Angel Wong is an Assistant Professor in Pharmacoepidemiology at the London School of Hygiene and Tropical Medicine. She studied BSc in Public Health at the Chinese University of Hong Kong and PhD in Pharmacoepidemiology at the University of Hong Kong. Her research interest is to use electronic health records to study medication effects and advanced methods to minimise bias and confounding. She has extensive experience in using routine clinical data from Hong Kong and the UK. She also used Japanese claims data to investigate the effect of heatwave on heat-related outcomes in people with severe mental disorders and depression. She is also one of the OpenSAFELY members to conduct numerous COVID-19 related research since pandemic in April 2020. She is now the course organiser of Professional Certificate course of Pharmacoepidemiology and Pharmacovigilance at LSHTM and deputy director of Centre for Global Chronic Conditions.
Moderator
Kinwei Chan
TriNetX LLC
Nobuhiro Oba